Document 2375
 DOCN  M94A2375
 TI    Analysis of HIV-I disease progression by race-ethnicity. Military
       Medical Consortium for Applied Retroviral Research.
 DT    9412
 AU    Levin LI; Chung RC; Milazzo M; Brundage JF; WRAIR, Washington DC.
 SO    Int Conf AIDS. 1994 Aug 7-12;10(1):319 (abstract no. PC0206). Unique
       Identifier : AIDSLINE ICA10/94370200
 AB    OBJECTIVE: To examine disease progression by race/ethnicity among
       patients seen at U.S. Army medical centers, we compared whites (n = 908)
       and blacks (n = 1301) presenting with the following CD4+ counts at their
       initial visit: (Cohort 1) CD4+ > 500; (Cohort 2) CD4+ 200-500; (Cohort
       3) CD4+ < 200. Initial CD4+ counts of seroconverters were also compared.
       METHODS: For life table analyses, whites were matched to blacks (1:1) on
       age (< 29, > or = 29), year of initial exam (< 1989, > or = 1989),
       gender, and initial CD4+ counts in 100 cell intervals. To estimate the
       relative hazard (RH) from the proportional hazard model, unmatched data
       were used with whites as the baseline and matching factors included to
       control for confounding TABULAR DATA, SEE ABSTRACT VOLUME. CONCLUSION:
       These analyses compared progression by race/ethnicity at four phases of
       HIV-1 disease among individuals in the U.S. Army, where there are no
       race/ethnic barriers to medical treatment. Overall, a pattern emerged
       where blacks had a somewhat better survival experience than whites, but
       not all analyses were statistically significant.
 DE    Adult  *Blacks  Comparative Study  Human  HIV
       Infections/ETHNOLOGY/*IMMUNOLOGY/MORTALITY  *HIV-1  Leukocyte Count
       Military Personnel  Survival Rate  T4 Lymphocytes  *Whites  MEETING
       ABSTRACT

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).